Condition
Left-sided Pancreatic Cancer
Total Trials
2
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
Treatment Research
4 treatments under study, led by Ldp
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Terminated1
Recruiting1
Clinical Trials (2)
Showing 2 of 2 trials
NCT05939063Not ApplicableRecruitingPrimary
LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer
NCT01875198Not ApplicableTerminatedPrimary
Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer
Showing all 2 trials
Research Network
Common Treatments
- Ldp1
- Radical Antegrade Modular Pancreatectomy Without Splenectomy1
- Radical Antegrade Modular Pancreatectomy With Splenectomy1
- Lramps1
Active Sponsors
- Qilu Hospital of Shandong University1
- The Third Affiliated Hospital of Soochow University1
- Yonsei University1
- Fudan University1
Top Investigators
Fudan University
Fudan University
Related Conditions
- Ductal Adenocarcinoma1